IR Information
Notice Regarding Results of Tender Offer for Share Certificates, Etc. of KAINOS Laboratories, Inc. (Securities Code: 4556)
Announcement of Extraordinary Gains (Gain on Sale of Investment Securities)
Summary of Q&A Session for Management Presentation on Feb 27 2026
News
Denka Recognized as a “KENKO Investment for Health Outstanding Organization (large enterprise category ~White 500~)” for the Fourth Consecutive Year
Notice Concerning Change in Equity-Method Affiliate (Becoming a Consolidated Subsidiary)
Presentation Materials for Management Presentation on Feb 27 2026 with Script
(Amendment) Notice Regarding Amendment to “Notice Regarding Commencement of Tender Offer for Share Certificates, Etc. of KAINOS Laboratories, Inc. (Securities Code: 4556)” and Public Notice of Commencementof Tender Offer Dueto Filingof Amendment Statement
This website uses cookies to ensure that you use this website comfortably. If you continue to browse this website, you will agree to the use of our cookies.